製品名:Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-

IUPAC Name:(4S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline

CAS番号:1870821-29-6
分子式:C16H14BrCl2N
純度:95%+
カタログ番号:CM429816
分子量:371.1

包装単位 有効在庫 価格(USD) 数量
CM429816-100mg in stock ƛƿȡ
CM429816-250mg in stock ƿƥũ
CM429816-1g in stock ȡƛȡ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1870821-29-6
分子式:C16H14BrCl2N
融点:-
SMILESコード:CN1C[C@@H](C2=CC(Br)=CC=C2)C2=C(C1)C(Cl)=CC(Cl)=C2
密度:
カタログ番号:CM429816
分子量:371.1
沸点:
MDL番号:MFCD27939616
保管方法:

Category Infos

Tetrahydroisoquinolines
Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.

Column Infos

Tenapanor
FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.